NA2 Stock Chart & Stats
€1.94
-€0.05(-2.51%)
At close: 4:00 PM EDT
€1.94
-€0.05(-2.51%)
Day’s Range― - ―
52-Week Range€1.71 - €4.06
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€12.46M
Enterprise Value€71.72M
Total Cash (Recent Filing)€9.20M
Total Debt (Recent Filing)€65.17M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Sep 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.36
Shares Outstanding6,275,229
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.29
Price to Sales (P/S)0.15
P/FCF Ratio8.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Revenue StreamsHaving two core revenue engines—contract manufacturing services and ingredient sales/licensing—provides structural resilience. Contract manufacturing yields recurring production revenue while ingredient licensing can scale royalties, reducing dependence on any single customer or model over 2–6 months.
Proprietary Ingredient (CarnoSyn®)Owning and commercializing CarnoSyn® gives NAII IP-based differentiation and potential licensing leverage. Proprietary ingredients create higher barriers to entry and recurring licensing opportunities, supporting sustainable margin improvement if demand in sports nutrition and supplements remains steady.
Material Equity BufferA sizeable equity base relative to assets provides a solvency buffer to absorb near-term losses and supports access to capital. This bolsters the company’s ability to fund operations or restructure terms while pursuing product or contract stability over the medium term.
Bears Say
Operating Losses And Thin Gross MarginPersistent operating losses and sub-10% gross margin indicate structural cost or pricing pressure in core manufacturing and ingredient sales. Low margins limit reinvestment capacity and make profitability highly sensitive to raw material or labor cost shocks, challenging sustainable returns.
Negative Operating And Free Cash FlowOngoing cash burn weakens liquidity and increases reliance on external financing or asset sales. Negative operating and free cash flow constrain the company’s ability to invest in capacity, R&D, or marketing, raising funding risk and limiting strategic flexibility over the next several quarters.
Rising LeverageMaterial increase in leverage reduces financial flexibility and raises refinancing and interest burden risks, especially while earnings are negative. Higher debt amplifies downside risk if margins and cash generation do not recover, pressuring solvency and strategic options.
Natural Alternatives International News
NA2 FAQ
What was Natural Alternatives International’s price range in the past 12 months?
Natural Alternatives International lowest stock price was €1.71 and its highest was €4.06 in the past 12 months.
What is Natural Alternatives International’s market cap?
Natural Alternatives International’s market cap is €12.46M.
When is Natural Alternatives International’s upcoming earnings report date?
Natural Alternatives International’s upcoming earnings report date is Sep 23, 2026 which is in 52 days.
How were Natural Alternatives International’s earnings last quarter?
Natural Alternatives International released its earnings results on May 19, 2026. The company reported -€0.627 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.627.
Is Natural Alternatives International overvalued?
According to Wall Street analysts Natural Alternatives International’s price is currently Overvalued.
Does Natural Alternatives International pay dividends?
Natural Alternatives International does not currently pay dividends.
What is Natural Alternatives International’s EPS estimate?
Natural Alternatives International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Natural Alternatives International have?
Natural Alternatives International has 6,275,229 shares outstanding.
What happened to Natural Alternatives International’s price movement after its last earnings report?
Natural Alternatives International reported an EPS of -€0.627 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.926%.
Which hedge fund is a major shareholder of Natural Alternatives International?
Currently, no hedge funds are holding shares in DE:NA2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Natural Alternatives International
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
Technical Analysis
Nature's Sunshine Products
―
Hain Celestial
―
USANA Health
―
LifeVantage
―
FitLife Brands
―









